Cargando…
Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced glioblastoma
BACKGROUND: Serclutamab talirine (Ser-T, formerly ABBV-321) is an antibody-drug conjugate consisting of an antibody (AM-1-ABT-806) directed against activated epidermal growth factor receptor (EGFR) and a pyrrolobenzodiazepine dimer. We investigated Ser-T monotherapy in a phase I, first-in-human, dos...
Autores principales: | Carneiro, Benedito A, Papadopoulos, Kyriakos P, Strickler, John H, Lassman, Andrew B, Waqar, Saiama N, Chae, Young Kwang, Patel, Jyoti D, Shacham-Shmueli, Einat, Kelly, Karen, Khasraw, Mustafa, Bestvina, Christine M, Merrell, Ryan, Huang, Kevin, Atluri, Harisha, Ansell, Peter, Li, Rachel, Jin, Janet, Anderson, Mark G, Reilly, Edward B, Morrison-Thiele, Gladys, Patel, Kalpesh, Robinson, Randy R, Aristide, Martha R Neagu, Gan, Hui K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940695/ https://www.ncbi.nlm.nih.gov/pubmed/36814898 http://dx.doi.org/10.1093/noajnl/vdac183 |
Ejemplares similares
-
Convection enhanced delivery of EGFR targeting antibody-drug conjugates Serclutamab talirine and Depatux-M in glioblastoma patient-derived xenografts
por: Porath, Kendra A, et al.
Publicado: (2022) -
Metastasis Initiation Precedes Detection of Primary Cancer—Analysis of Metastasis Growth in vivo in a Colorectal Cancer Test Case
por: Hochman, Gili, et al.
Publicado: (2020) -
The impact of overall radiotherapy treatment time and delay in initiation of radiotherapy on local control and distant metastases in gastric cancer
por: Soyfer, Viacheslav, et al.
Publicado: (2014) -
Reducing Skin Toxicities from EGFR Inhibitors with Topical BRAF Inhibitor Therapy
por: Lacouture, Mario E., et al.
Publicado: (2021) -
Serological response to a third booster dose of BNT162b2 COVID‐19 vaccine among seronegative cancer patients
por: Shmueli, Einat Shacham, et al.
Publicado: (2022)